Key facts
- GoodBelly’s last known valuation is $85.0M (Dec 2025).
- It has raised $55.7M; the latest was Later Stage VC ($10.0M) in Dec 2025.
- Notable investors include 301, Emil Capital Partners, Sadhu Capital.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for GoodBelly
- ·The full record, as it builds
Funding rounds
No funding rounds for GoodBelly are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GoodBelly
Manufacturer of probiotic-enriched beverages and dietary supplements intended for digestive health support. The company's platform features a range of dairy-free juice drinks, concentrated wellness shots, and shelf-stable capsules formulated with clinically studied bacterial strains and prebiotic fibers, enabling health-conscious consumers to maintain optimal intestinal microflora balance, improve nutrient absorption, and bolster immune system function through a variety of natural, plant-based nutritional formats.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Boulder, CO, United States
- Founded
- 2006
- Employees
- 15
- Website
- goodbelly.com/
- Ownership
- Privately Held (backing)
GoodBelly doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GoodBelly shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GoodBelly in its N-PORT filings yet. We sweep new filings monthly.